Is this you? Create Your Porfile
Avatar

Mark M. Aloysius

Icahn School of Medicine at Mount Sinai

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Mark M. Aloysius is active.

Explore More

Publication

Featured researches published by Mark M. Aloysius.

Open Journal of Gastroenterology | 2014

The effect of melatonin in functional heartburn: A randomized, placebo-controlled clinical trial

Patrick Basu; Hemanth Hempole; Nitya Krishnaswamy; Niraj J. Shah; Mark M. Aloysius

Hpb | 2016

Sofosbuvir and ledipasvir versus sofosbuvir and simeprevir combination therapy in the management of acute hepatitis c: A Randomized open label prospective study. SLAM C study

Patrick Basu; N.J. Shah; L. Kavali; Mark M. Aloysius

Hpb | 2016

Sofosbuvir, ledipasvir in IBD treated patients with advanced biologics including ribavirin eradicating chronic hepatitis C: SOLATAIRE C Trial. A multi-center clinical prospective pilot study

Patrick Basu; N.J. Shah; L. Kavali; Mark M. Aloysius; Robert S. Brown

Open Journal of Gastroenterology | 2014

Randomized, Placebo-Controlled Trial of Transdermal Rivastigmine for the Treatment of Encephalopathy in Liver Cirrhosis (TREC Trial)

Patrick Basu; Niraj J. Shah; Mark M. Aloysius; Robert S. Brown

Gastroenterology | 2018

Sa1445 - Prevalence of Acute Hepatitis E Infection in Community: A Cross-Sectional Cohort Study in New York

Patrick Basu; Nimy John; Menisa Zaman; Mark M. Aloysius

Gastroenterology | 2018

Su1610 - Selecting Spinal Cord Injury Patients for Structured Biofeedback Therapy to Improve Anorectal Function

Mark M. Aloysius; William A. Bauman; Miroslav Radulovic; Tradd M. Cummings; Anton Sabiev; Ann M. Spungen; Brian Lyons; Sandeep Kahal; Joshua C. Hobson; Mark A. Korsten

Gastroenterology | 2018

Mo1468 - Isolated Immunoglobulin IGG 4 Related Clinical Entity in Extra Luminal Overt Celiac Disease: An Observational Clinical Pilot Study

Patrick Basu; Nimy John; Menisa Zaman; Mark M. Aloysius

Hpb | 2016

Sofosbuvir and ledipasvir in attainment of SVR12 in sickle cell disease (SCD) sub-population with chronic hepatitis C (CHC). A single center prospective study-SLASH C trial

Patrick Basu; N.J. Shah; L. Kavali; Mark M. Aloysius

Gastrointestinal Endoscopy | 2016

Mo1361 Low Titer Endomysial Antibody (EMA) in Non-Celiac Population Segregated From a Community With Immune Mediated Vasculitis. an Observational Study

Patrick Basu; Niraj J. Shah; L. Kavali; Mark M. Aloysius; Sakina Farhat

Gastroenterology | 2016

Su1445 Ombitasvir (ABT 267), Ritanavir Boost With Dastasbuvir (ABT 333) and Prataspravir (ABT 450) With or Without Ribavirin (RBV) in G1 Special Population in Hemodialysis (HD) in Chronic Hepatitis C (HCV) Patients. Drop C Trial: An Open Label Prospective Clinical Pilot Study

Patrick Basu; Niraj J. Shah; Sakina Farhat; Nimy John; L. Kavali; Mark M. Aloysius

Explore More

Collaboration

Dive into the Mark M. Aloysius's collaboration.

Top Co-Authors
Avatar

Patrick Basu

Columbia University

View shared research outputs
Top Co-Authors
Avatar

Niraj J. Shah

Icahn School of Medicine at Mount Sinai

View shared research outputs
Top Co-Authors
Avatar

L. Kavali

King's

View shared research outputs
Top Co-Authors
Avatar

Robert S. Brown

Cornell University

View shared research outputs
Top Co-Authors
Avatar

N.J. Shah

University of North Carolina at Chapel Hill

View shared research outputs
Top Co-Authors
Avatar

Nimy John

King's

View shared research outputs
Top Co-Authors
Avatar

Sakina Farhat

King's

View shared research outputs
Top Co-Authors
Avatar

Ann M. Spungen

Icahn School of Medicine at Mount Sinai

View shared research outputs
Top Co-Authors
Avatar

Krishna Rayapudi

North Shore University Hospital

View shared research outputs
Top Co-Authors
Avatar

Mark A. Korsten

Icahn School of Medicine at Mount Sinai

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge